Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)

Market Cap	4.93B -5.9%
Revenue (ttm)	1.68B -18.1%
Net Income	62.86M -72.2%
EPS	0.05 -74.9%
Shares Out	1.19B
PE Ratio	84.48
Forward PE	n/a
Dividend	0.04 (0.97%)
Ex-Dividend Date	Sep 25, 2025

Volume	8,616,367
Average Volume	18,624,374
Open	4.070
Previous Close	4.110
Day's Range	4.070 - 4.150
52-Week Range	3.780 - 5.480
Beta	0.36
RSI	47.57
Earnings Date	Apr 27, 2026

About SHE:300194

Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China. It offers APIs; intermediates; and FFPs, such as anti-tumor, generic drugs, antibiotics and oral, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. The company was founded in 2004 and is headquartered in Chongqing, the Peopl...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2004
• Employees: 3,392
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300194

Financial Performance

In 2025, SHE:300194's revenue was 1.74 billion, a decrease of -27.31% compared to the previous year's 2.39 billion. Earnings were 77.00 million, a decrease of -72.49%.